GSTM1 Gene and Lung Cancer in Turkey
Author Information
Author(s): Demir Adalet, Altin Sedat, Pehlivan Davut, Demir Mulahim, Yakar Fatih, Seyhan Ekrem Cengiz, Dincer Seyyit Ibrahim
Primary Institution: Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Istanbul, Turkey
Hypothesis
Does GSTM1 gene polymorphism influence lung cancer susceptibility in the Turkish population?
Conclusion
GSTM1 genotype is not an independent risk factor for lung cancer.
Supporting Evidence
- The prevalence of GSTM1-null genotype was 49% in lung cancer patients.
- The control group had a GSTM1-null genotype prevalence of 52.6%.
- No significant relationships were found between GSTM1 genotypes and histopathologic types of lung cancers.
Takeaway
This study looked at a gene that might affect lung cancer risk in Turkish people, but it found that having this gene doesn't really change the chances of getting lung cancer.
Methodology
DNA samples were extracted from blood and analyzed using PCR to determine GSTM1 genotypes in lung cancer patients and healthy controls.
Potential Biases
Potential biases due to regional variations in the control population.
Limitations
The study may not account for all genetic and environmental factors influencing lung cancer risk.
Participant Demographics
102 lung cancer patients and 154 healthy controls, with a mean age of 56.3 for patients and 35.1 for controls.
Statistical Information
P-Value
0.57
Confidence Interval
95% CI = 0.70–1.90
Statistical Significance
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website